top of page
NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
54838-0135-40 | Q0163 | DIPHENHYDRAMINE HYDROCHLORIDE, 50 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT TIME OF CHEMOTHERAPY TREATMENT NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | SILADRYL ALLERGY (AF,SF) 12.5 MG/5 ML | PO |
54838-0135-70 | Q0163 | DIPHENHYDRAMINE HYDROCHLORIDE, 50 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT TIME OF CHEMOTHERAPY TREATMENT NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | SILADRYL ALLERGY 12.5 MG/5 ML | PO |
54838-0135-80 | Q0163 | DIPHENHYDRAMINE HYDROCHLORIDE, 50 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT TIME OF CHEMOTHERAPY TREATMENT NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | SILADRYL ALLERGY (AF,SF) 12.5 MG/5 ML | PO |
54838-0154-40 | Q0163 | DIPHENHYDRAMINE HYDROCHLORIDE, 50 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT TIME OF CHEMOTHERAPY TREATMENT NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | SILPHEN 12.5 MG/5 ML | PO |
54838-0154-70 | Q0163 | DIPHENHYDRAMINE HYDROCHLORIDE, 50 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT TIME OF CHEMOTHERAPY TREATMENT NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | SILPHEN 12.5 MG/5 ML | PO |
54838-0154-80 | Q0163 | DIPHENHYDRAMINE HYDROCHLORIDE, 50 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT TIME OF CHEMOTHERAPY TREATMENT NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | SILPHEN 12.5 MG/5 ML | PO |
54868-0026-00 | Q0163 | DIPHENHYDRAMINE HYDROCHLORIDE, 50 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT TIME OF CHEMOTHERAPY TREATMENT NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | DIPHENHYDRAMINE HCL 25 MG | PO |
62756-0060-40 | J1325 | INJECTION, EPOPROSTENOL, 0.5 MG | EPOPROSTENOL (SDV,LYOPHILIZED) 1.5 MG | IV |
62756-0073-60 | J9198 | INJECTION, GEMCITABINE HYDROCHLORIDE, (INFUGEM), 100 MG | INFUGEM (LATEX-FREE) 1200 MG/120 ML | IV |
62756-0073-60 | J9199 | INJECTION, GEMCITABINE HYDROCHLORIDE (INFUGEM), 200 MG | INFUGEM (LATEX-FREE) 1200 MG/120 ML | IV |
62756-0090-40 | J1050 | INJECTION, MEDROXYPROGESTERONE ACETATE, 1 MG | MEDROXYPROGESTERONE ACETATE 150 MG/1 ML | IM |
62756-0090-45 | J1050 | INJECTION, MEDROXYPROGESTERONE ACETATE, 1 MG | MEDROXYPROGESTERONE ACETATE (SDV) 150 MG/1 ML | IM |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page